6 completed, 1 active not recruiting. 3 Not applicable, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Bioavailability Heathy Volunteers: new trials by email Literature Review of Bioavailability Heathy Volunteers trials Research Report on Bioavailability Heathy Volunteers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Assess the Pharmacokinetic Profile of Three Coenzyme Q10 Formulations in Healthy Adults VitaDry-Q10, VitaSperse-Q10, Coenzyme Q10 - Pharmacokinetic Parameters, Bioavailability Heathy Volunteers | Not applicable | Completed | 3i Solutions | 20 | 2026-04-03 | 2026-07-08 |
| Bioavailability of Phlorotannins and Carotenoids Following the Intake of Crackers Fortified With Seaweed Seaweed cracker, Control cracker - Bioavailability Heathy Volunteers, Bioavailability and AUC | Not applicable | Active not recruiting | National Research Council, Spain | 10 | 2026-03-01 | 2026-04-02 |
| A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects FDC (24 mg ER torsemide and 30 mg Spironolactone) without food, FDC (24 mg ER torsemide and 30 mg Spironolactone) with food - Bioavailability Heathy Volunteers | Phase 3 | Completed | Sarfez Pharmaceuticals, Inc. | 24 | 2025-06-15 | 2026-03-06 |
| Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone Torsemide and Spironolactone tablet, Torsemide Tablets and Spironolactone Tablets - Bioavailability Heathy Volunteers | Phase 3 | Completed | Sarfez Pharmaceuticals, Inc. | 24 | 2025-06-15 | 2026-03-09 |
| Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state. 150 mg trazodone hydrochloride, 300 mg trazodone hydrochloride - Bioavailability Heathy Volunteers, Bioavailability Study | Phase 1 | Completed | Aziende Chimiche Riunite Angelini Francesco S.p.A | 64 | 2024-05-22 | 2025-09-03 |
| Pharmacokinetics and Safety of a New Micellar Glutathione Formulation Liposomal Glutathione, Standard Glutathione, New Micellar Glutathione (Lipomicel) - Bioavailability Heathy Volunteers, Safety | Not applicable | Completed | Factors Group of Nutritional Companies Inc. | 16 | 2022-06-21 | 2026-02-27 |
| Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration. Ticagrelor 90 mg whole tablet, Ticagrelor 90 mg tablet crushed, Dispersed ticagrelor 90 mg tablet suspended in water - nasogastric tube - Bioavailability Heathy Volunteers | Phase 1 | Completed | AstraZeneca | 36 | 2013-07-01 | 2013-09-18 |
Spironolactone (2) · Ticagrelor (1) · Torsemide (1) · Trazodone (1) · coenzyme Q10 (1) · glutathione pegylated liposomal doxorubicin (1)
Sarfez Pharmaceuticals, Inc. (2) · 3i Solutions (1) · AstraZeneca (1) · Aziende Chimiche Riunite Angelini Francesco S.p.A (1) · Factors Group of Nutritional Companies Inc. (1) · National Research Council, Spain (1)
Canada (2) · United States (2) · Germany (1) · Spain (1) · United Kingdom (1)
Salim Shah, PhD, JD (2) · Judith Hsia, MD (1) · Julia Solnier, PhD (1) · Mirjana Kujacic, MD (1) · Saeed Kahn, MBBS (1)